Q: Thoughts for a 3-5 year hold? Is it more "defensive" than the overall sector bc of the types of drugs they make?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Cambrex has been dropping and I can't find any news. Thoughts?
Q: Hi !
Nearly a year ago, you mentioned Silicon Motion and Cambrex as your favorite US growth stocks. Where do you see them going now ?
As I am down 17% on Cambrex and 8% on Silicon Motion, do you think I should hold, sell or average down ?
Thank you for your enlightened views,
Jacques
Nearly a year ago, you mentioned Silicon Motion and Cambrex as your favorite US growth stocks. Where do you see them going now ?
As I am down 17% on Cambrex and 8% on Silicon Motion, do you think I should hold, sell or average down ?
Thank you for your enlightened views,
Jacques
Q: On 12.July 2016 I sold from my US margin acc. CBM (US) with $2,190 profit (capital gain).
Later on 5th. of August I bought CBM again an sold it on 22.Aug. with $929 loss.
My question is:can I claim in my 2016 tax return this loss of $929 against profit of $2,190 from previously sold on 12.July CBM.
Thanks Andrew
Later on 5th. of August I bought CBM again an sold it on 22.Aug. with $929 loss.
My question is:can I claim in my 2016 tax return this loss of $929 against profit of $2,190 from previously sold on 12.July CBM.
Thanks Andrew
Q: Hi Peter and Team,
I was asked to resubmit due to name of company was dropped off.
My question was about Cambrex Corp in US which you recommended before, do you still like it, share price dropped after qtr earning report, pls give your update, is it buyable?
Thank you as always.
I was asked to resubmit due to name of company was dropped off.
My question was about Cambrex Corp in US which you recommended before, do you still like it, share price dropped after qtr earning report, pls give your update, is it buyable?
Thank you as always.